AU2001253767A1 - Method of treating, preventing or inhibiting central nervous system injuries and diseases - Google Patents

Method of treating, preventing or inhibiting central nervous system injuries and diseases

Info

Publication number
AU2001253767A1
AU2001253767A1 AU2001253767A AU5376701A AU2001253767A1 AU 2001253767 A1 AU2001253767 A1 AU 2001253767A1 AU 2001253767 A AU2001253767 A AU 2001253767A AU 5376701 A AU5376701 A AU 5376701A AU 2001253767 A1 AU2001253767 A1 AU 2001253767A1
Authority
AU
Australia
Prior art keywords
diseases
treating
preventing
nervous system
central nervous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253767A
Inventor
Michael L. Koenig
James L. Meyerhoff
Debra L. Yoorick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Army Medical Research and Materiel Command USAMRMC
Original Assignee
US Army Medical Research and Materiel Command USAMRMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Army Medical Research and Materiel Command USAMRMC filed Critical US Army Medical Research and Materiel Command USAMRMC
Publication of AU2001253767A1 publication Critical patent/AU2001253767A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001253767A 2000-04-21 2001-04-20 Method of treating, preventing or inhibiting central nervous system injuries and diseases Abandoned AU2001253767A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19895800P 2000-04-21 2000-04-21
US60198958 2000-04-21
PCT/US2001/013043 WO2001080851A1 (en) 2000-04-21 2001-04-20 Method of treating, preventing or inhibiting central nervous system injuries and diseases

Publications (1)

Publication Number Publication Date
AU2001253767A1 true AU2001253767A1 (en) 2001-11-07

Family

ID=22735607

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253767A Abandoned AU2001253767A1 (en) 2000-04-21 2001-04-20 Method of treating, preventing or inhibiting central nervous system injuries and diseases

Country Status (2)

Country Link
AU (1) AU2001253767A1 (en)
WO (1) WO2001080851A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182060A1 (en) * 2004-02-13 2005-08-18 Kelly Michael G. 2-Substituted and 4-substituted aryl nitrone compounds
WO2008083204A2 (en) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation of neurogenesis by melatoninergic ligands
US10744115B2 (en) * 2017-04-25 2020-08-18 Ischemix Llc Compositions and methods for treating traumatic brain injury
WO2024026200A1 (en) * 2022-07-27 2024-02-01 Redox Bioscience LLC Methods and compounds for treating ulcerative colitis, systemic lupus erythematosus, sepsis, and post-sepsis syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid

Also Published As

Publication number Publication date
WO2001080851A1 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
AU9262598A (en) Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
MXPA01009544A (en) Method for treating and/or preventing retinal diseases with sustained release corticosteroids.
AU2754201A (en) Method and system for treating cardiac arrest
IL162447A0 (en) Methods for slowing senescence and treating and preventing diseases associated with senescence
EP1109580A4 (en) Methods for treating or preventing viral infections and associated diseases
EP1115286A4 (en) Methods for treating or preventing viral infections and associated diseases
IL144118A0 (en) Multi-electrode catheter, system and method
HUP0200495A2 (en) Method of treating eating disorders
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
AU2002211612A1 (en) Methods for the treatment of a traumatic central nervous system injury
AU2002240453A1 (en) Wastewater treatment system and method of control
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
PL361947A1 (en) Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
AU2001243219A1 (en) Methods of prevention and treatment of asthma, and allergic conditions
EP1043983A4 (en) Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system
AU5838700A (en) Method for treating and preventing finger disorders
AU2002232400A1 (en) Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
AU2001240046A1 (en) Method of treating skin conditions
AU2001265081A1 (en) Wastewater treatment system and method
EP1051169A4 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
AU2002344823A1 (en) System and method for treating fires
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
AU2001253767A1 (en) Method of treating, preventing or inhibiting central nervous system injuries and diseases
EP0921803A4 (en) Methods for preventing and treating pestivirus infection and associated diseases